Caribou Biosciences, Inc. (CRBU)
0.4736
+0.01
(+2.91%)
USD |
NASDAQ |
Oct 12, 09:55
Caribou Biosciences EPS Diluted (Quarterly) : -0.2404 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2404 |
| March 31, 2026 | -0.2617 |
| December 31, 2025 | -0.2802 |
| September 30, 2025 | -0.2953 |
| June 30, 2025 | -0.5815 |
| March 31, 2025 | -0.4315 |
| December 31, 2024 | -0.3893 |
| September 30, 2024 | -0.3834 |
| June 30, 2024 | -0.4173 |
| March 31, 2024 | -0.4617 |
| December 31, 2023 | -0.3902 |
| September 30, 2023 | -0.1194 |
| June 30, 2023 | -0.4806 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.4583 |
| December 31, 2022 | -0.4424 |
| September 30, 2022 | -0.4376 |
| June 30, 2022 | -0.4394 |
| March 31, 2022 | -0.3153 |
| December 31, 2021 | -0.3066 |
| September 30, 2021 | -0.3494 |
| June 30, 2021 | -0.2386 |
| March 31, 2021 | -0.2194 |
| December 31, 2020 | -0.2452 |
| September 30, 2020 | -0.1322 |
| June 30, 2020 | -0.0312 |
| March 31, 2020 | -0.1634 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.7989 |
| Vir Biotechnology, Inc. | 0.4742 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.28M |
| Revenue (Quarterly) | 1.499M |
| Total Expenses (Quarterly) | 25.78M |
| Enterprise Value | -36.88M |
| Gross Profit Margin (Quarterly) | 58.31% |
| Profit Margin (Quarterly) | -1.62K% |
| Earnings Yield | -227.5% |
| Normalized Earnings Yield | -227.53 |